CYTOCLONAL PHARMACEUTICS, INC. – Trademark Portfolio
Entity Type: 03
CYTOCLONAL PHARMACEUTICS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes. The owner is based in Dallas, TX.
9000 Harry Hines Blvd.
Dallas, TX 75235
Showing of trademarks Trademarks
Trademark Classifications
CYTOCLONAL PHARMACEUTICS, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CYTOCLONAL PHARMACEUTICS, INC. have?
CYTOCLONAL PHARMACEUTICS, INC. has 5 U.S. trademarks filed with the USPTO.
What trademark classes does CYTOCLONAL PHARMACEUTICS, INC. file in?
CYTOCLONAL PHARMACEUTICS, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is CYTOCLONAL PHARMACEUTICS, INC.'s trademark registration success rate?
CYTOCLONAL PHARMACEUTICS, INC. has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.